Pre-IPO Brii Biosciences - Insights on Pipeline and Related Concerns
This insight mainly analyzed the core product candidates of Brii Biosciences in the pipeline (HBV, COVID-19 products and others), the competitive...
557 Views
What HKEX Biotech "Step-Ups" Can Tell Us
This Insight explains the concept of valuation "step-ups" for pre-revenue biotechnology companies listing on the HKEX and how to use this data to...
582 Views
HSCI and Stock Connect - Biotech Stocks Now Eligible; Inclusion & Exclusion Possibilities
Hang Seng Indexes Company (HSIL) reviews the constituents of the Hang Seng Composite Index (HSCI) on a half yearly basis in March and September...
1.1k Views
Trade Idea: Close the SHORT on Ascletis Pharma and Pocket 26% Profit
We initiated trade idea on Ascletis Pharma on the hype surrounding its drug candidates being reported to be used in clinical trial to treat...
477 Views
Asia-Pac Stocks Priced For Liquidation
When investors are chucking in the towel, including the event space (RV, risk arb etc.), it's time for some old school perspective. In this...
917 Views